Chromatography Resin Companies

In terms of value, the chromatography resin market is projected to grow from USD 3.02 billion in 2024 to USD 4.94 billion by 2030, with a CAGR of 8.6% from 2025 to 2030. Separation and purification chromatography resins play a crucial role in chromatography. Their ability to meet the increasing demand for high-purity products, especially in pharmaceutical, biotechnology, food and beverage, and environmental testing, makes them widely used. These resins are designed for isolating specific compounds, removing impurities, and ensuring the safety and uniformity of the product. They are routinely used in developing and manufacturing monoclonal antibodies, vaccines, diagnostics, and food additives, as they enable precise, reproducible separations even in complex mixtures. Since chromatography resins are subject to high global quality standards and regulatory requirements, adoption is necessary. The industry's shift toward biopharmaceuticals, personalized medicines, and clean-label foods has underscored the need for effective purification tools. With ongoing advancements in bioseparation technologies and increasing demands for safer, more efficient, and sustainable processes in biotechnological production, chromatography resins will continue to play a vital role in ensuring product quality and regulatory compliance in international markets.

Chromatography Resin Companies

The key players profiled in the report include Bio-Rad Laboratories, Inc. (US), Merck KgaA (Germany), Danaher Corporation (US), Tosoh Corporation (Japan), Sartorius Stedim Biotech S.A. (France), Bio-Works Technologies AB (Sweden), Avantor, Inc. (US), Purolite (US), Repligen Corporation (US), Mitsubishi Chemical Group Corporation (Japan), and Thermo Fisher Scientific Inc. (US), among others. These players have adopted various growth strategies to strengthen their position in the market. These include introducing new technologies, expansions, acquisitions, and product launches to acquire larger market shares.

To know about the assumptions considered for the study download the pdf brochure

Danaher Corporation is a US-based, globally diversified conglomerate that designs, manufactures, and markets professional, medical, industrial, and commercial products and services. In 2020, Danaher acquired the GE Healthcare life sciences business and renamed it Cytiva. Currently, Danaher is offering chromatography resins through its acquired standalone company, Cytiva. It operates its business through three reportable segments: biotechnology, life sciences, and diagnostics. These segments offer a wide range of research tools that are used to study the basic building blocks of life, including genes, proteins, metabolites, and cells, to understand the cause of diseases, identify new therapies, and test new drugs and vaccines. It offers chromatography resins through the life sciences segment. The company operates in 40 countries and territories covering Europe, Asia, North and Latin America, and the Middle East. It hosts customer-centered innovation facilities across Asia, Europe, and the Americas to carry ideas to commercial development. In February 2024, Danaher Corporation (Cytiva) planned to open a new resin manufacturing facility with an investment of USD 500 million in Shrewsbury, Massachusetts. Cytiva’s new facility is dedicated to increasing production capacity for chromatography resins, supporting the growing demand for bioprocessing solutions in North America.

Tosoh Corporation is a Japan-based company. The company operates its business through five reportable segments: specialty, chlor-alkali, petrochemical, engineering, and other. It caters to end-use industries such as bioscience, chemical, electronics, information technology, automotive, construction, and environmental. The company offers chromatography products through its bioscience segment, a sub-segment of the specialty segment. The company has a wide distribution network in Asia Pacific. Tosoh Corporation comprises over 100 companies worldwide in the regions of Europe, Asia Pacific, the Middle East & Africa, North America, and South America. By developing and manufacturing instruments and reagents, the company aims to expand its business in its target fields and broaden its market presence as one of the core businesses of the specialty group. In February 2024, Tosoh Corporation expanded its production capacity for Toyopearl and TSKgel chromatography resins at its facilities in Japan.

The chromatography resin market is consolidated, with four major players holding approximately 55-60% of the global market share. Danaher Corporation leads the segment with its extensive range of chromatography resins and broad integration across various applications. Tosoh Corporation maintains a strong market position, focusing on chromatography resins and global supply operations, particularly in Japan and the Americas. Merck KGaA continues its upward growth trend through strategic acquisitions and market expansion. Bio-Rad Laboratories, Inc. also holds a solid position with its new-generation chromatography resins. The remaining 40-45% of the market consists of regional small-scale manufacturers and companies. Market competition is driven by technological advances in chromatography resin, increasing demand for sustainable and durable materials, and expanding applications of chromatography resin.

Related Reports:

Chromatography Resin Market by Type (Natural, Synthetic, Inorganic Media), Technique {(Ion Exchange (Cation and Anion), Affinity (Hydrophobic Interaction, Mixed Mode)}, Application (Pharmaceutical & Biotechnology), and Region - Global Forecast to 2030